ICN37805

• CAT Number: I029139
• CAS Number: 1191237-80-5
• Molecular Formula: C15H17N5O4
• Molecular Weight: 331.33
• Purity: 98%
• Synonyms: Remdesivir related compound 7; ICN37805; ICN-37805; ICN 37805; Remdesivir-intermediate.
• Target: Anti-infection
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: (3aR,4R,6R,6aR)-4-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-6-(hydroxymethyl)-2,2-dimethyl-6,6a-dihydro-3aH-furo[3,4-d][1,3]dioxole-4-carbonitrile
• InChI: InChI=1S/C15H17N5O4/c1-14(2)23-11-9(5-21)22-15(6-16,12(11)24-14)10-4-3-8-13(17)18-7-19-20(8)10/h3-4,7,9,11-12,21H,5H2,1-2H3,(H2,17,18,19)/t9-,11-,12-,15+/m1/s1
• InChIKey: IJCOKJGMVJGKBB-CGEWXTDFSA-N
• SMILES: CC1(O[C@@H]2[C@H](O[C@@]([C@@H]2O1)(C#N)C3=CC=C4N3N=CN=C4N)CO)C

ICN37805（Cat No.:I029139）is an experimental compound being studied for its potential as an anticancer agent. It belongs to a class of molecules that target specific cellular pathways involved in cancer cell proliferation and survival. ICN37805 is thought to exert its effects by modulating key enzymes or signaling pathways that regulate cell cycle progression and apoptosis. Preclinical studies have shown promise in its ability to inhibit tumor growth and overcome drug resistance in certain cancer types. However, its clinical development and safety profile are still under investigation, and further research is required to assess its therapeutic potential.